N

Novartis

Global pharmaceutical company delivering science-based innovations

Associate Director - ADC platform in Oncology Drug Discovery

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • A Ph.D. in cancer biology, pharmacology, chemical biology, biochemistry, medicinal chemistry, bioengineering, or a related discipline.
  • Five to ten years of relevant industry experience in antibody-drug conjugate discovery, targeted therapeutics, or oncology drug discovery.
  • Extensive expertise in antibody-drug conjugate payloads, including mechanism of action, potency, resistance biology, and therapeutic index considerations.
  • Strong knowledge of linker and conjugation technologies, including stability, release mechanisms, site-specific conjugation, and developability.
  • Deep understanding of antibody-drug conjugate biology, including tumor targeting, internalization, trafficking, payload release, bystander effects, and pharmacology.
  • Demonstrated ability to integrate biology, chemistry, and translational data into actionable program strategies.
  • Proven experience leading cross-functional scientific discussions and influencing program direction.

Responsibilities

  • Lead scientific strategy for antibody-drug conjugate payload selection, linker design, conjugation approaches, and related platform innovations.
  • Apply expertise across payload classes, mechanisms of action, potency, resistance biology, bystander activity, and tolerability to guide program design.
  • Partner with chemistry, biology, protein engineering, pharmacology, translational sciences, and chemistry, manufacturing, and controls teams to advance next-generation antibody-drug conjugates.
  • Evaluate and prioritize novel payloads, linker technologies, and conjugation approaches for internal programs and external opportunities.
  • Provide biology-driven insights into payload mechanism of action, tumor context, therapeutic index, and combination strategies.
  • Design and guide experimental strategies to assess antibody-drug conjugate activity, selectivity, resistance mechanisms, linker stability, and payload-related pharmacology.
  • Contribute to next-generation antibody-drug conjugate platform strategy, including differentiated payload-linker concepts and biology-aligned design.
  • Represent payload and linker expertise in cross-functional project teams, governance discussions, and external collaborations.
  • Monitor scientific, clinical, competitive, and intellectual property landscapes related to antibody-drug conjugate payloads, linkers, and emerging targeted modalities.
  • Mentor scientists and contribute to a collaborative research environment.

About the Company

Novartis

Global pharmaceutical company delivering science-based innovations

Novartis is a global pharmaceutical company that uses science-based innovations to develop treatments and improve patient outcomes worldwide. Its products are medicines developed through research and development to address various diseases, aiming to reach nearly 1 billion people. The company differentiates itself by large-scale investment in R&D, a global presence with a diverse workforce, and a clear mission to Reimagine Medicine, focusing on meeting the changing needs of patients. Its goal is to improve quality of life and extend life expectancy by delivering meaningful therapies through its research and development efforts.

Company size
10,001+
Company stage
IPO
Headquarters
Basel, Switzerland
Founded
1970

Recently Posted Jobs

Explore more opportunities at Novartis

See more jobs